Patent · US Active

Targeted ubiquitination degradation BRD4 protein compound, preparation method therefor and application thereof

US12358925B2 · kind B2 · utility

0Cited by

1References

9Claims

0Family size

Assignee

CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. · CN

Inventors

Chuanwu Zhao · Shijiazhuang, CN
Chunhua Jiang · Shanghai, CN
Yan Zhang · Fort Washington, US
Xuejiao Zhang · Hangzhou City, CN
Jinlu Yang · Shijiazhuang, CN
Jieqiong Kang · Shijiazhuang, CN
Peipei ZHAO · Shanghai, CN

Key dates

Filing date	Feb 3, 2020
Grant date	Jul 15, 2025
Priority date	—
Expiry date	Nov 17, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound represented by formula (I) or a tautomer, optical isomer, deuterated substance, oxynitride, solvate, pharmaceutically acceptable salt or prodrug thereof can be used in preparing a pharmaceutical composition. The compound or the pharmaceutical composition can be used in the preparation a drug for the prevention and/or treatment of cancer, tumors, viral infections, depression, neurological disorders, trauma, age-related cataracts, organ transplant rejection or autoimmune diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.